Jupiter Asset Management LTD Amgen Inc Transaction History

Jupiter Asset Management LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $255,361 - $292,238	-1,284 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $272,554 - $319,330	1,284 New	1,284 $273,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $6.37 Million - $7.42 Million	-28,693 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $5.47 Million - $6.51 Million	25,278 Added 740.2%	28,693 $6.6 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $801,329 - $891,144	3,415 New	3,415 $867,000
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $1.39 Million - $1.63 Million	-8,334 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $6.19 Million - $6.98 Million	-34,216 Reduced 80.41%	8,334 $1.58 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $2.86 Million - $3.34 Million	-16,039 Reduced 27.38%	42,550 $8.12 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $190,107 - $214,321	1,026 Added 1.78%	58,589 $12.2 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $1.8 Million - $2.11 Million	-10,649 Reduced 15.61%	57,563 $9.81 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $11.4 Million - $13 Million	68,212	68,212 $12.7 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.